"In GC, CBR3-AS1 and PCA3 may be utilized as therapeutic targets and prognostic biomarkers, respectively."

BUFFALO, NY- June 5, 2025 – A new research paper was published in Volume 16 of Genes & Cancer on May 9, 2025, titled "Evaluation of LncRNAs CBR3-AS1 and PCA3 expression in Gastric cancer and their correlation to clinicopathological variables."

Researchers, led by first author Parisa Najari and corresponding author Reza Safaralizadeh from the University of Tabriz,

Impact Journals is pleased to participate as an exhibitor at the Society for Scholarly Publishing (SSP) 47th Annual Meeting from May 28–30, 2025, in Baltimore, Maryland.

BUFFALO, NY – May 5, 2025 – Impact Journals (Genes & Cancer’s publisher) is pleased to announce its participation as an exhibitor at the upcoming Society for Scholarly Publishing (SSP) 47th Annual Meeting. The event will take place from May 28-30, 2025, in Baltimore, Maryland.

Attendees are invited to visit

Impact Journals is proud to participate in the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25-30 in Chicago, Illinois.

BUFFALO, NY – March 17, 2025 – Impact Journals (Genes & Cancer’s publisher) is pleased to announce its participation as an exhibitor at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. The meeting is scheduled for April 25-30, 2025, at the McCormick Place Convention Center in

“In other words, the pR552^* mutant behaves more like a gain-of-function or oncogenic mutant. Indeed, a family carrying this mutation showed complete penetrance and high expressivity.”

BUFFALO, NY- January 29, 2025 – A new research paper was published in Volume 16 of Genes & Cancer on January 20, 2025, entitled, “Analysis of pathogenic variants in retinoblastoma reveals a potential gain of function mutation.”

Researchers from Instituto de Física Universidad Autónoma de San Luis Potosí and